Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To compare the effect of once-daily dosing of 14 mg oral semaglutide versus 1.8 mg liraglutide subcutaneous and versus placebo, all in combination with metformin with or without a SGLT-2 inhibitor, on glycaemic control in subjects with type 2 diabetes mellitus (T2DM).
Critère d'inclusion
- Diabetes Mellitus, Type 2